Home / Health / Hospital Recalls Defective Seizure & Heart Meds
Hospital Recalls Defective Seizure & Heart Meds
1 Oct
Summary
- Ten medicine batches failed quality tests or had physical defects.
- Powdered tablets of isosorbide mononitrate and metoprolol recalled.
- No severe adverse effects reported; interim medicine arrangements made.
Dr Ram Manohar Lohia Hospital initiated a recall of ten medicine batches due to quality concerns and physical defects. Notices were issued between September 7 and 14, directing departments to cease using and return affected stock. These included tablets for seizures (sodium valproate), heart conditions (spironolactone, metoprolol), depression (imipramine), and postpartum bleeding (methyl ergometrine).
Further recalls involved injectable medicines like adenosine and multivitamins, all failing analytical testing. Two tablet batches, isosorbide mononitrate and metoprolol, were found in powder form within their strips, with specific manufacturing and expiry dates flagged. These batches were manufactured by Glowson India Labs Pvt Ltd.
The hospital confirmed that some samples were supplied by M/s Jackson Laboratories Pvt Ltd. While clinical uses of the withdrawn medicines are diverse, RML Hospital stated no severe adverse effects have been reported. Interim measures are in place to prevent patient care disruption, and the situation is under close monitoring.
